124 related articles for article (PubMed ID: 7932243)
1. Association of overexpression of p53 oncoprotein with the state of cell proliferation in oral carcinoma.
Warnakulasuriya KA; Johnson NW
J Oral Pathol Med; 1994 Jul; 23(6):246-50. PubMed ID: 7932243
[TBL] [Abstract][Full Text] [Related]
2. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
3. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
[TBL] [Abstract][Full Text] [Related]
4. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
[TBL] [Abstract][Full Text] [Related]
5. Epithelial growth fraction and expression of p53 tumour suppressor gene in oral submucous fibrosis.
Cox SC; Walker DM
Aust Dent J; 1996 Apr; 41(2):91-6. PubMed ID: 8670041
[TBL] [Abstract][Full Text] [Related]
6. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
Brustmann H; Naudé S
Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
[TBL] [Abstract][Full Text] [Related]
7. Expression of the tumour suppressor gene p53 in oral cancer.
Langdon JD; Partridge M
Br J Oral Maxillofac Surg; 1992 Aug; 30(4):214-20. PubMed ID: 1380822
[TBL] [Abstract][Full Text] [Related]
8. p53, PCNA and Ki-67 expression in oral squamous cell carcinomas: the vagaries of fixation and microwave enhancement of immunocytochemistry.
Allison RT; Best T
J Oral Pathol Med; 1998 Oct; 27(9):434-40. PubMed ID: 9790097
[TBL] [Abstract][Full Text] [Related]
9. PCNA and P53 expression in relation to clinicopathological features of oral papilloma.
Sulkowska M; Famulski W; Stasiak-Barmuta A; Kasacka I; Koda M; Chyczewski L; Sulkowski S
Folia Histochem Cytobiol; 2001; 39 Suppl 2():193-4. PubMed ID: 11820603
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
[TBL] [Abstract][Full Text] [Related]
11. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
[TBL] [Abstract][Full Text] [Related]
12. [Value of monoclonal antibodies (PC 10, MIB1, p53 and LeuM 1) for assessing the prognosis of patients with squamous epithelial carcinoma of the larynx after partial laser resection].
Hake R; Eckel H; von Pritzbuer E; Volling P; Thiele J
Pathologe; 1995 May; 16(3):197-203. PubMed ID: 7792271
[TBL] [Abstract][Full Text] [Related]
13. Altered expression of mdm-2 and its association with p53 protein status, tumor-cell-proliferation rate and prognosis in cervical neoplasia.
Dellas A; Schultheiss E; Almendral AC; Gudat F; Oberholzer M; Feichter G; Moch H; Torhorst J
Int J Cancer; 1997 Aug; 74(4):421-5. PubMed ID: 9291432
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].
Sittel C; Ruiz S; Kvasnicka HM; Volling P; Jungehülsing M; Eckel HE
Laryngorhinootologie; 2000 Feb; 79(2):86-92. PubMed ID: 10738715
[TBL] [Abstract][Full Text] [Related]
15. p53 immunostaining as a marker for oral cancer in diagnostic cytopathology--preliminary report.
Ogden GR; Cowpe JG; Chisholm DM; Lane DP
Cytopathology; 1994 Feb; 5(1):47-53. PubMed ID: 8173031
[TBL] [Abstract][Full Text] [Related]
16. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
[TBL] [Abstract][Full Text] [Related]
17. Changes in p53 and cyclin D1 protein levels and cell proliferation in different stages of human esophageal and gastric-cardia carcinogenesis.
Wang LD; Shi ST; Zhou Q; Goldstein S; Hong JY; Shao P; Qiu SL; Yang CS
Int J Cancer; 1994 Nov; 59(4):514-9. PubMed ID: 7960222
[TBL] [Abstract][Full Text] [Related]
18. The significance of PCNA and p53 protein in some oral tumors.
Tsuji T; Mimura Y; Wen S; Li X; Kanekawa A; Sasaki K; Shinozaki F
Int J Oral Maxillofac Surg; 1995 Jun; 24(3):221-5. PubMed ID: 7594756
[TBL] [Abstract][Full Text] [Related]
19. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical localization of p53, PCNA, and TGF-alpha proteins in formaldehyde-induced rat nasal squamous cell carcinomas.
Wolf DC; Gross EA; Lyght O; Bermudez E; Recio L; Morgan KT
Toxicol Appl Pharmacol; 1995 May; 132(1):27-35. PubMed ID: 7747282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
